Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregoire Le Gal

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2018
Who should get long-term anticoagulant therapy for venous thromboembolism and with what?Marc Alan Rodger, Gregoire Le Gal
Blood Advances|November 15, 2018
Who should get long-term anticoagulant therapy for venous thromboembolism and with what?Marc Alan Rodger, Gregoire Le Gal
Clinical Interventions in Aging|November 6, 2008
Primary prevention of venous thromboembolism in elderly medical patientsKarine Lacut, Gregoire Le Gal, Dominique Mottier
The New England Journal of Medicine|May 30, 2019
Preventing Venous Thromboembolism in Patients with Cancer. ReplyMarc Carrier, Gregoire Le Gal, Philip S Wells
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. ReplyLana A Castellucci, Gregoire Le Gal, Marc Rodger, et al.
Annals of Internal Medicine|May 4, 2011
Assessment of recurrence risk after unprovoked venous thromboembolismMarc A Rodger, Timothy Ramsay, Gregoire Le Gal, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2019
Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomesJoseph R Shaw, James Douketis, Gregoire Le Gal, et al.
Thrombosis Research|July 20, 2014
Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarinAbirami Vijenthira, Gregoire Le Gal, Lana A Castellucci, et al.
Thrombosis|May 12, 2017
Referral Patterns and Diagnostic Yield of Lung Scintigraphy in the Diagnosis of Acute Pulmonary EmbolismMatthieu Pelletier-Galarneau, Erik Zannier, Lionel S Zuckier, et al.
Thrombosis and Haemostasis|February 16, 2005
Phenotypic but not allelic ABO blood group association with risk of venous thrombosisBernard Mercier, Emmanuel Oger, Gregoire Le Gal, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Hematology. American Society of Hematology. Education Program|December 4, 2018
Who should get long-term anticoagulant therapy for venous thromboembolism and with what?Marc Alan Rodger, Gregoire Le Gal
Blood Advances|November 15, 2018
Who should get long-term anticoagulant therapy for venous thromboembolism and with what?Marc Alan Rodger, Gregoire Le Gal
Clinical Interventions in Aging|November 6, 2008
Primary prevention of venous thromboembolism in elderly medical patientsKarine Lacut, Gregoire Le Gal, Dominique Mottier
The New England Journal of Medicine|May 30, 2019
Preventing Venous Thromboembolism in Patients with Cancer. ReplyMarc Carrier, Gregoire Le Gal, Philip S Wells
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. ReplyLana A Castellucci, Gregoire Le Gal, Marc Rodger, et al.
Annals of Internal Medicine|May 4, 2011
Assessment of recurrence risk after unprovoked venous thromboembolismMarc A Rodger, Timothy Ramsay, Gregoire Le Gal, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2019
Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomesJoseph R Shaw, James Douketis, Gregoire Le Gal, et al.
Thrombosis Research|July 20, 2014
Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarinAbirami Vijenthira, Gregoire Le Gal, Lana A Castellucci, et al.
Thrombosis|May 12, 2017
Referral Patterns and Diagnostic Yield of Lung Scintigraphy in the Diagnosis of Acute Pulmonary EmbolismMatthieu Pelletier-Galarneau, Erik Zannier, Lionel S Zuckier, et al.
Thrombosis and Haemostasis|February 16, 2005
Phenotypic but not allelic ABO blood group association with risk of venous thrombosisBernard Mercier, Emmanuel Oger, Gregoire Le Gal, et al.
Pageof 7